We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $8.21B
1-Year Est. Return 28.81%
This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+28.81%
3 Year Est. Return
+92.54%
5 Year Est. Return
+114.67%
10 Year Est. Return
+429.8%
AUM
$3.35B
AUM Growth
+$61.6M
Cap. Flow
-$6.39M
Cap. Flow %
-0.19%
Top 10 Hldgs %
14.63%
Holding
1,352
New
104
Increased
455
Reduced
536
Closed
129

Sector Composition

Rank Sector Weight
1 Healthcare 14.91%
2 Financials 10.04%
3 Industrials 9.49%
4 Technology 9.43%
5 Consumer Discretionary 8.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXLG icon
1101
Destination XL Group
DXLG
$29.3M
$198K 0.01%
43,300
+3,000
+7% +$14.9K
NRK icon
1102
Nuveen New York AMT-Free Quality Municipal Income Fund
NRK
$903M
$197K 0.01%
13,774
+1,527
+12% +$21.2K
WSTC
1103
DELISTED
West Corporation
WSTC
$197K 0.01%
+10,000
New +$215K
RIGL icon
1104
Rigel Pharmaceuticals
RIGL
$704M
$193K 0.01%
8,676
-601
-6% -$14.9K
BOX icon
1105
Box
BOX
$4.31B
$192K 0.01%
+18,555
New +$222K
LUMO
1106
DELISTED
Lumos Pharma, Inc. Common Stock
LUMO
$188K 0.01%
1,856
-866
-32% -$107K
JRO
1107
DELISTED
Nuveen Floating Rate Income Opportunty Fund
JRO
$187K 0.01%
+18,170
New +$185K
PTY icon
1108
PIMCO Corporate & Income Opportunity Fund
PTY
$2.49B
$186K 0.01%
13,234
EOD
1109
Allspring Global Dividend Opportunity Fund
EOD
$277M
$185K 0.01%
31,000
+12
+0% +$72
UBS icon
1110
UBS Group
UBS
$175B
$185K 0.01%
+14,273
New +$218K
NMO
1111
DELISTED
NUVEEN MUNI MARKET OPPORT FUND
NMO
$184K 0.01%
12,225
-4,875
-29% -$71.9K
AFB
1112
AllianceBernstein National Municipal Income Fund
AFB
$314M
$183K 0.01%
12,100
UCFC
1113
DELISTED
United Community Financial Corp
UCFC
$182K 0.01%
30,000
NMBL
1114
DELISTED
Nimble Storage, Inc.
NMBL
$182K 0.01%
22,764
-1,021
-4% -$7.95K
CLMS
1115
DELISTED
Calamos Asset Management, Inc.
CLMS
$175K 0.01%
23,983
+11,800
+97% +$93.4K
STM icon
1116
STMicroelectronics
STM
$47.3B
$174K 0.01%
29,500
-3,000
-9% -$17.2K
DB icon
1117
Deutsche Bank
DB
$69.6B
$172K 0.01%
14,092
+2,240
+19% +$33.6K
FTF
1118
Franklin Limited Duration Income Trust
FTF
$232M
$167K 0.01%
14,400
BBF
1119
DELISTED
BlackRock Municipal Income Investment Trust
BBF
$161K ﹤0.01%
+10,073
New +$155K
SWC
1120
DELISTED
Stillwater Mining Co
SWC
$160K ﹤0.01%
13,450
-1,750
-12% -$18.7K
NFJ
1121
Virtus Dividend, Interest & Premium Strategy Fund
NFJ
$1.41B
$159K ﹤0.01%
12,855
+121
+1% +$1.49K
HTY
1122
DELISTED
JOHN HANCOCK TAX-ADVANTAGED GLOBAL SHAREHOLDER YIELD FUND
HTY
$159K ﹤0.01%
15,350
FTR
1123
DELISTED
Frontier Communications Corp.
FTR
$159K ﹤0.01%
2,138
-368
-15% -$28.8K
VGM icon
1124
Invesco Trust Investment Grade Municipals
VGM
$553M
$156K ﹤0.01%
10,500
-4,000
-28% -$57.5K
ACTG icon
1125
Acacia Research
ACTG
$426M
$155K ﹤0.01%
35,300
-9,700
-22% -$44.6K

Similar funds

Oppenheimer & Co's Q2 2016 Portfolio in Review

As of Q2 2016, Oppenheimer & Co held 1,352 positions worth $3.35B, up 1.9% from $3.29B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Oppenheimer & Co's Q2 2016 filing shows 104 new, 455 increased, 536 reduced and 129 closed positions. Its largest new stake was WisdomTree India Earnings Fund ETF: 201,376 shares worth $4.07M. The largest sale was Energy Transfer Partners L.p., an estimated $6.24M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Financials and Industrials.

  • Oppenheimer & Co's largest Q2 2016 buy was WisdomTree India Earnings Fund ETF: 201,376 shares worth $4.07M.
  • Oppenheimer & Co added most to Foundation Medicine, Inc. in Q2 2016, an estimated $4.54M increase.
  • Oppenheimer & Co's biggest Q2 2016 reduction was Energy Transfer Partners L.p., cutting an estimated $6.24M.
  • Oppenheimer & Co fully exited Wolfspeed in Q2 2016, selling an estimated $4.45M.
  • Oppenheimer & Co's ten largest holdings make up 15% of its $3.35B portfolio in Q2 2016.
  • Oppenheimer & Co opened 104 new positions and closed 129 in Q2 2016.
  • Oppenheimer & Co's portfolio value rose 1.9% quarter-over-quarter to $3.35B.

Based on Oppenheimer & Co's 13F filing for Q2 2016, filed 8 Aug 2016.